0 items USD 0.00Search
Your search for "current partnering age related macular degeneration partnering 2009 2014" gave back 38264 results.
Market Analysis and Insights: Global Posterior Segment Eye Disorder Treatment Market The global Posterior Segment Eye Disorder Treatment market is...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Retinal Biosimilars Industry Forecast” looks at past sales and reviews total world Retinal Biosimilars sales in 2022, providing a comprehensive...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Retinal Biosimilars market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Lucentis (Ranibizumab) and Biosimilar market size was valued at USD 1156.5 million in 2022 and is forecast to a readjusted size of USD 971...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
EYLEA® (aflibercept) Injection 2 mg (0.05mL) is a prescription medicine approved for the treatment of patients with Wet Age-related Macular...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others. The global...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
